Alterations of Golgi organization in Alzheimer's disease: A cause or a consequence?

被引:25
|
作者
Ayala, Inmaculada [1 ]
Colanzi, Antonino [1 ]
机构
[1] CNR, Inst Prot Biochem, Via P Castellino 111, I-80131 Naples, Italy
来源
TISSUE & CELL | 2017年 / 49卷 / 02期
关键词
Golgi complex; Membrane trafficking; Signalling; Neurodegeneration; Alzheimer's disease; PRECURSOR PROTEIN; FRAGMENTATION; APPARATUS; COMPLEX; TAU; GRASP65; STRESS; RIBBON; ACTIVATION; ORGANELLE;
D O I
10.1016/j.tice.2016.11.007
中图分类号
R602 [外科病理学、解剖学]; R32 [人体形态学];
学科分类号
100101 ;
摘要
The Golgi apparatus is a central organelle of the secretory pathway involved in the post-translational modification and sorting of lipids and proteins. In mammalian cells, the Golgi apparatus is composed of stacks of cisternae organized in polarized manner, which are interconnected by membrane tubules to constitute the Golgi ribbon, located in the proximity of the centrosome. Besides the processing and transport of cargo, the Golgi complex is actively involved in the regulation of mitotic entry, cytoskeleton organization and dynamics, calcium homeostasis, and apoptosis, representing a signalling platform for the control of several cellular functions, including signalling initiated by receptors located at the plasma membrane. Alterations of the conventional Golgi organization are associated to many disorders, such as cancer or different neurodegenerative diseases. In this review, we examine the functional implications of modifications of Golgi structure in neurodegenerative disorders, with a focus on the role of Golgi fragmentation in the development of Alzheimer's disease. The comprehension of the mechanism that induces Golgi fragmentation and of its downstream effects on neuronal function have the potential to contribute to the development of more effective therapies to treat or prevent some of these disorders. (C) 2016 Elsevier Ltd. All rights reserved.
引用
收藏
页码:133 / 140
页数:8
相关论文
共 50 条
  • [41] Alzheimer's Disease The β-amyloid degrading the Golgi apparatus
    Cavicchioli, Lionel
    BIOFUTUR, 2014, (354) : 7 - 7
  • [42] Heterogeneity of Alzheimer's disease: consequence for drug trials?
    Devi, Gayatri
    Scheltens, Philip
    ALZHEIMERS RESEARCH & THERAPY, 2018, 10
  • [43] Heterogeneity of Alzheimer’s disease: consequence for drug trials?
    Gayatri Devi
    Philip Scheltens
    Alzheimer's Research & Therapy, 10
  • [44] Depression in Alzheimer's disease: consequence or contributing factor?
    Mintzer, Jacobo
    O'Neill, Courtney
    EXPERT REVIEW OF NEUROTHERAPEUTICS, 2011, 11 (11) : 1501 - 1503
  • [45] Cause of death in Alzheimer's disease
    Beard, CM
    Kokmen, E
    Sigler, C
    Smith, GE
    Petterson, T
    OBrien, PC
    ANNALS OF EPIDEMIOLOGY, 1996, 6 (03) : 195 - 200
  • [46] Pathogens as a cause of Alzheimer's disease
    Kinoshita, J
    NEUROBIOLOGY OF AGING, 2004, 25 (05) : 639 - 640
  • [47] Synaptic alterations in the medial geniculate bodies and the inferior colliculi in Alzheimer's disease: a Golgi and electron microscope study
    Baloyannis, Stavros J.
    Mauroudis, Ioannis
    Manolides, Spyros L.
    Manolides, Leonidas S.
    ACTA OTO-LARYNGOLOGICA, 2009, 129 (04) : 416 - 418
  • [48] Synaptic alterations in the medial geniculate bodies and the inferior colliculi in Alzheimer's disease: a Golgi and electron microscope study
    Baloyannis, S. J.
    Mavroudis, J.
    EUROPEAN JOURNAL OF NEUROLOGY, 2008, 15 : 225 - 225
  • [49] Brain Metabolic Alterations in Alzheimer's Disease
    Ardanaz, Carlos G.
    Ramirez, Maria J.
    Solas, Maite
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2022, 23 (07)
  • [50] Alzheimer's Disease and Histone Code Alterations
    Narayan, Pritika
    Dragunow, Mike
    NEUROEPIGENOMICS IN AGING AND DISEASE, 2017, 978 : 321 - 336